Plandai Biotech is selling for 2.0E-4 as of the 24th of November 2024. This is a 100.00 percent increase since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Plandai Biotech has more than 62 % chance of experiencing financial distress in the next few years of operation. However, it had a very solid returns during the last 90 days. Equity ratings for Plandai Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of November 2023 and ending today, the 24th of November 2024. Click here to learn more.
Planda Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. Planda Biotechnology, Inc. is based in London, the United Kingdom. Diamond Ranch is traded on OTC Exchange in the United States. The company has 263.19 M outstanding shares. More on Plandai Biotech
Plandai Biotech [PLPL] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 276.35 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Plandai Biotech's market, we take the total number of its shares issued and multiply it by Plandai Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Plandai Biotech conducts business under Biotechnology sector and is part of Health Care industry. The entity has 263.19 M outstanding shares.
Plandai Biotech currently holds about 7.96 K in cash with (1.1 M) of positive cash flow from operations.
Check Plandai Biotech Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Plandai Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run My Watchlist Analysis Now
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Other Information on Investing in Plandai Pink Sheet
Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.